New Cancer Treatment Disguises Drugs as Platelets
A new cancer treatment technique recently published in the Advanced Materials medical journal uses a disguise method to better target cancer cells. By disguising anticancer drugs as platelets, the anticancer drugs are able to remain in the body longer and are actually attracted by the cancer cells.
The anticancer drugs are coated in platelet membranes, making them appear as a normal blood platelet on the surface. Cancer cells stick to platlets, so coating the drug in platelet membranes allows the drugs to target the main tumor, as well as stick to cancer cells in the bloodstream that may cause cancer to spread to other parts of the body.
Using the body’s own platelet membranes also allows the anticancer drugs to avoid detection as foreign substances. This increases longevity of the drug in the patient’s system, giving it more time to attach to and destroy the cancer cells.
So far the technique has been used successfully in mice using a combination of the anticancer drugs doxorubicin and TRAIL. When administered normally, these drugs typically only lasted six hours in the bloodstream.Using the platelet disguise technique, the drugs were still working in the bloodstream up to 30 hours later.
Researchers are looking to perform more preclinical trials before moving on to human clinical trials. Study author, professor Zhen Gu, hopes that the technique can also be used for other drug treatments such as those for cardiovascular disease.
Cancer Treatments are a Leading Cause of Disability – We Are Here to Support You
Chemotherapy and other cancer treatments are often the reason cancer patients cannot return to work. The devastating side-effects of these treatments often leave patients too fatigued to work, and therefore may make them eligible for Social Security disability benefits. Contact the Disability Help Group for help with your disability claim. Call us at 1-(800)-800-3332.